Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | FP-1305 |
Trade Name | |
Synonyms | FP1305|FP 1305|Clevegen|Bexmarilimab |
Drug Descriptions |
FP-1305 is a humanized IgG4 antibody that targets the scavenger receptor Clever-1 on tumor-associated macrophages, which may lead to and may lead to immune cell activation (J. Clin. Onc., 2020, 38(15), pp.3097). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C159536 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
FP-1305 | FP-1305 | 0 | 1 |
FP-1305 + Pembrolizumab | FP-1305 Pembrolizumab | 0 | 1 |